World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   7045 records for 1192 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
AuthorisedEUCTR2014-005663-32-LV
Study of efficacy and safety of secukinumab in pediatric patients with severe plaque psoriasis.
12/06/2015
AuthorisedEUCTR2015-001588-37-EE
A Study of Plazomicin Compared with Meropenem followed by Optional Oral Therapy for the Treatment of Complicated Urinary Tract Infection (cUTI), including Acute Pyelonephritis (AP) 11/06/2015
AuthorisedEUCTR2014-003997-18-LT
A study investigating Immune Globuline (Human), 10% Caprylate/Chromatography Purified (IGIV-C) for the treatment of patients with Myasthenia Gravis. The patients will receive 2g/kg of IP as a loading dose. The loading dosage is followed by maintenance doses of 1 g/kg administered every third week until Visit 8 (Week 21). 25/05/2015
AuthorisedEUCTR2013-005099-17-LT
A study investigating Immune Globuline (Human), 10% Caprylate/Chromatography Purified (IGIV-C) for the treatment of patients with Myasthenia Gravis, dependent on Corticosteroids. The patients will receive 2g/kg of IP as a loading dose. The loading dosage is followed by maintenance doses of 1 g/kg administered every third week until Visit 13 (Week 36). During maintenance doses the investigator will try to slowly reduce the patient's corticosteroid dose. 25/05/2015
AuthorisedEUCTR2015-000050-38-LT
Study to demonstrate the efficacy (including inhibition of structural damage), safety and tolerability up to 2 years of secukinumab in Active Psoriatic Arthritis 25/05/2015
RecruitingNCT02455999
Dose-finding Study to Assess the Safety and Effect of SYL1001 in Patients With Ocular Pain
20/05/2015
AuthorisedEUCTR2015-000486-31-EE
The effect of milrinone in preterm neonates after open arterial duct operation.
19/05/2015
AuthorisedEUCTR2014-003453-34-EE
Study of a new drug’s effect in people with rheumatoid arthritis who have not responded sufficiently well to treatment with Methotrexate.
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2014-003453-34-HUStudy of a new drug’s effect in people with rheumatoid arthritis who have not responded sufficiently well to treatment with Methotrexate.27/05/2015
14/05/2015
AuthorisedEUCTR2014-003420-46-EE
A study to evaluate the similarity in efficacy and safety of Mylan Adalimumab (MYL-1401A) Compared With Humira® in Subjects With Moderate-to-Severe Chronic skin inflammatory disease.
14/05/2015
Not recruitingNCT02471144
Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis
04/05/2015
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history